FDA Inspection 1135809 — Provention Bio
The FDA completed an inspection of Provention Bio on February 4, 2021 in Red Bank, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Red Bank, NJ (United States)
Additional Details
Sponsor, Contract Research Organization